tirzepatide weight loss plateau causes Overcome a Plateau: Strategies & Services Why am I not losing
Description
Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)

Appetite Control

Some patients tolerate one medication better than the other

Yes, but you need to provide at least 48 hours notice before your renewal date

Proteins in food are normally broken down in the stomach and intestines

When you inject at the same time each week, your system develops a rhythm